Close
FINDING CURES TOGETHER<sup>SM</sup>
Andrew J. Phillips, PhD

Chairperson
Andrew J. Phillips, PhD
(2019-2020)
President and Chief Scientific Officer
​C4 Therapeutics
Cambridge, Massachusetts

Philip Jones, PhD

Chairperson-elect
Philip Jones, PhD
(2019-2020)
Vice President, Therapeutics Discovery, and Head of Drug Discovery
UT MD Anderson Cancer Center​
Houston, Texas

Julian Blagg, DPhil

Past Chairperson
Julian Blagg, DPhil
(2019-2020)
Vice President, Drug Discovery
NeoPhore & Azeria Therapeutics
Cambridge, United Kingdom

Julian Adams, PhD

Julian Adams, PhD
(2018-2020)
CEO and Chairman
Gamida-Cell
Cambridge, Massachusetts

James E. Audia, PhD

James E. Audia, PhD
(2019-2021)
Executive Director
Chicago Biomedical Consortium, Northwestern University​
Evanston, Illinois

James R. Bischoff, PhD

James R. Bischoff, PhD
(2018-2020)
Global Head Targeted Therapy-Oncology
Roche Applied Science​
Basel, Switzerland

Michael Brands, Dr. Rer.Nat

Michael Brands, Dr. Rer.Nat
(2018-2020)
Senior Vice President Drug Discovery-Small Molecule Innovation
Bayer Pharma AG​
Berlin, Germany

Sara J. Buhrlage, PhD

Sara J. Buhrlage, PhD
(2018-2020)
Assistant Professor of Biological Chemistry and Molecular Pharmacology
Dana-Farber Cancer Institute​
Boston, Massachusetts

Ivan Cornella-Taracido, PhD

Ivan Cornella-Taracido, PhD
(2019-2021)
Vice President, Proteomics and Chemical Biology
Cedilla Therapeutics​
Cambridge, Massachusetts

Chudi O. Ndubaku, PhD

Chudi O. Ndubaku, PhD
(2019-2021)
Associate Director, Chemistry
Aduro Biotech​
Berkeley, California

Xiaojing (Gina) Wang

Xiaojing (Gina) Wang
(2019-2021)
Principal Scientist and Project Team Lead
Genentech, Inc.​
South San Francisco, California